These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1128 related articles for article (PubMed ID: 28352154)
1. HMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivo. Jiang S; Chen X Drug Des Devel Ther; 2017; 11():783-795. PubMed ID: 28352154 [TBL] [Abstract][Full Text] [Related]
2. Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers. Mohammad G; Alam K; Nawaz MI; Siddiquei MM; Mousa A; Abu El-Asrar AM J Physiol Biochem; 2015 Sep; 71(3):359-72. PubMed ID: 26040511 [TBL] [Abstract][Full Text] [Related]
3. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina. Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026 [TBL] [Abstract][Full Text] [Related]
4. Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats. Sohn E; Kim J; Kim CS; Lee YM; Kim JS Nutrients; 2016 Mar; 8(3):140. PubMed ID: 26950148 [TBL] [Abstract][Full Text] [Related]
5. HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy. Liang WJ; Yang HW; Liu HN; Qian W; Chen XL Life Sci; 2020 Jan; 241():117146. PubMed ID: 31816325 [TBL] [Abstract][Full Text] [Related]
6. Involvement of HMGB1 mediated signalling pathway in diabetic retinopathy: evidence from type 2 diabetic rats and ARPE-19 cells under diabetic condition. Chen XL; Zhang XD; Li YY; Chen XM; Tang DR; Ran RJ Br J Ophthalmol; 2013 Dec; 97(12):1598-603. PubMed ID: 24133029 [TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Box-1 Protein Mediates the Regulation of Signal Transducer and Activator of Transcription-3 in the Diabetic Retina and in Human Retinal Müller Cells. Mohammad G; Jomar D; Siddiquei MM; Alam K; Abu El-Asrar AM Ophthalmic Res; 2017; 57(3):150-160. PubMed ID: 27560926 [TBL] [Abstract][Full Text] [Related]
8. The role of high mobility group box 1 (HMGB-1) in the diabetic retinopathy inflammation and apoptosis. Yu Y; Yang L; Lv J; Huang X; Yi J; Pei C; Shao Y Int J Clin Exp Pathol; 2015; 8(6):6807-13. PubMed ID: 26261566 [TBL] [Abstract][Full Text] [Related]
9. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats. Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733 [TBL] [Abstract][Full Text] [Related]
10. Bradykinin alleviates DR retinal endothelial injury by regulating HMGB-1/NF-κB pathway. Zhu Y; Li XY; Wang J; Zhu YG Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5535-5541. PubMed ID: 31298304 [TBL] [Abstract][Full Text] [Related]
11. Intraocular Delivery of miR-146 Inhibits Diabetes-Induced Retinal Functional Defects in Diabetic Rat Model. Zhuang P; Muraleedharan CK; Xu S Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1646-1655. PubMed ID: 28297724 [TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic translocation of high-mobility group box-1 protein is induced by diabetes and high glucose in retinal pericytes. Kim J; Kim CS; Sohn E; Kim JS Mol Med Rep; 2016 Oct; 14(4):3655-61. PubMed ID: 27599553 [TBL] [Abstract][Full Text] [Related]
13. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes. Li J; Wang P; Ying J; Chen Z; Yu S Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397 [TBL] [Abstract][Full Text] [Related]
15. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats. Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990 [TBL] [Abstract][Full Text] [Related]
16. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Mohammad G; Siddiquei MM; Othman A; Al-Shabrawey M; Abu El-Asrar AM Exp Eye Res; 2013 Feb; 107():101-9. PubMed ID: 23261684 [TBL] [Abstract][Full Text] [Related]
17. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Kumar B; Gupta SK; Nag TC; Srivastava S; Saxena R; Jha KA; Srinivasan BP Exp Eye Res; 2014 Aug; 125():193-202. PubMed ID: 24952278 [TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTTIP improves diabetic retinopathy by regulating the p38-MAPK pathway. Sun Y; Liu YX Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2941-2948. PubMed ID: 29863235 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-a attenuates retinal inflammation by inhibiting HMGB-1 formation in rats with type 2 diabetes mellitus. Wang P; Chen F; Zhang X BMC Pharmacol Toxicol; 2020 Feb; 21(1):9. PubMed ID: 32019593 [TBL] [Abstract][Full Text] [Related]
20. LncRNA ANRIL knockdown ameliorates retinopathy in diabetic rats by inhibiting the NF-κB pathway. Wei JC; Shi YL; Wang Q Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7732-7739. PubMed ID: 31599399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]